Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DNA topoisomerase 1–DNA cleavage complex (Top1-DNA CC) is a transient catalytic intermediate formed during the action of the enzyme DNA topoisomerase 1. Under normal physiological conditions, Top1 relieves torsional strain in DNA by creating a reversible single-strand break, forming a covalent bond between a tyrosine residue and the 3' phosphate of the DNA backbone [1, 2]. This allows the DNA to rotate and relax before the enzyme re-ligates the strand. However, this complex becomes a potent therapeutic target when stabilized by specific inhibitors, such as camptothecin derivatives [1, 3]. These drugs act as interfacial inhibitors, trapping the Top1-DNA CC and preventing the re-ligation step [2]. When DNA replication forks or transcription machinery encounter these stabilized complexes, they are converted into permanent, lethal double-strand breaks, ultimately triggering programmed cell death [1, 3]. This mechanism is widely exploited in oncology for the treatment of various solid tumors, including colorectal and ovarian cancers [1, 4]. Citations: [1] Pommier Y. (2006). Nature Reviews Cancer. [2] Pommier Y. (2013). ACS Chemical Biology. [3] Thomas C. J., et al. (2004). Bioorganic & Medicinal Chemistry. [4] UniProt (2024). P11387 (TOP1_HUMAN).
Interfacial inhibition; stabilization of the covalent Top1-DNA intermediate to prevent re-ligation, resulting in replication-mediated DNA double-strand breaks.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA topoisomerase 1–DNA cleavage complex (Top1-DNA CC) (Top1-DNA CC).